-
The FDA has approved injectable poly-L-lactic acid, an injectable filler to correct facial fat loss in HIV patients.
-
The FDA has developed a web page to consolidate records of advisory committee meetings related to HIV/AIDS and associated conditions, making them easier to access.
-
-
Organizations successfully targeting Latino populations for HIV services and prevention have developed strategies specific to very different groups, including young men who have sex with men (MSM); rural, low-income Hispanics, and Latino migrants or Mexican border town residents.
-
A new study reports success in reducing risk and improving womens housing and employment status after enrollment in a woman-focused HIV intervention program.
-
The Centers for Disease Control and Prevention (CDC) is focusing on the role of physicians in its prevention for positives initiative, but according to one survey funded by the agency, the available prevention counseling is less than optimal.
-
While the latest reports show enrollment of children in SCHIP declined during the second half of 2003 the first enrollment decline since the program was enacted in 1997 the need for it remains great, and the American Academy of Pediatrics said more federal funding support for the program is needed.
-
Expansions in public health insurance programs are designed to offer a safety net to vulnerable Americans unable to obtain basic health insurance and regular access to medical care.
-
One unintended consequence of the nations health care safety net which includes public hospitals, community health centers, local clinics, and some primary care physicians is that it is crowding out, or replacing, other insurance options for unmarried childless adults, according to new research by Anthony Lo Sasso, research associate professor at the Institute for Policy Research at Northwestern University.
-
Struggling with skyrocketing drug costs, West Virginia lawmakers are poised to go head to head with the powerful pharmaceutical industry, potentially becoming the first state to impose price controls on prescription drugs.
